Get the Stockscreener App
88.55
1.96%
-1.77
After Hours:
88.65
0.10
+0.11%
Netflix Inc stock is traded at $88.55, with a volume of 49.36M.
It is down -1.96% in the last 24 hours and down -6.98% over the past month.
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
See More
Previous Close:
$90.32
Open:
$91.24
24h Volume:
49.36M
Relative Volume:
1.13
Market Cap:
$375.62B
Revenue:
$43.33B
Net Income/Loss:
$10.43B
P/E Ratio:
36.99
EPS:
2.3937
Net Cash Flow:
$8.97B
1W Performance:
-2.40%
1M Performance:
-6.98%
6M Performance:
-29.83%
1Y Performance:
+6.89%
1-Day Range:
$87.95
$91.58
1-Week Range:
$87.95
$91.58
52-Week Range:
$82.11
$134.12
Netflix Inc Stock (NFLX) Company Profile
Name
Netflix Inc
Sector
Industry
Phone
408-540-3700
Address
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NFLX
Netflix Inc
|
88.55 | 383.13B | 43.33B | 10.43B | 8.97B | 2.3937 |
|
DIS
Walt Disney Co
|
113.53 | 201.70B | 94.18B | 13.43B | 10.08B | 6.8524 |
|
WBD
Warner Bros Discovery Inc
|
28.63 | 71.56B | 37.87B | 356.00M | 4.13B | 0.1876 |
|
LYV
Live Nation Entertainment Inc
|
146.78 | 33.91B | 24.57B | 532.09M | 1.59B | 1.37 |
|
FOXA
Fox Corporation
|
73.09 | 32.51B | 16.47B | 2.07B | 2.67B | 4.4433 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Initiated | HSBC Securities | Buy |
| Jan-09-26 | Reiterated | Goldman | Neutral |
| Dec-08-25 | Downgrade | Pivotal Research Group | Buy → Hold |
| Dec-08-25 | Downgrade | Rosenblatt | Buy → Neutral |
| Nov-18-25 | Reiterated | Barclays | Equal Weight |
| Oct-31-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-07-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Sep-17-25 | Upgrade | Loop Capital | Hold → Buy |
| Jul-10-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-07-25 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jul-02-25 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-25 | Reiterated | Goldman | Neutral |
| Jun-20-25 | Reiterated | Pivotal Research Group | Buy |
| Jun-12-25 | Reiterated | Oppenheimer | Outperform |
| Jun-03-25 | Reiterated | Jefferies | Buy |
| May-30-25 | Reiterated | BofA Securities | Buy |
| May-19-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-21-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-21-25 | Reiterated | Barclays | Equal Weight |
| Apr-21-25 | Reiterated | Canaccord Genuity | Buy |
| Apr-21-25 | Reiterated | Guggenheim | Buy |
| Apr-21-25 | Reiterated | JP Morgan | Overweight |
| Apr-21-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-21-25 | Reiterated | MoffettNathanson | Buy |
| Apr-21-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-21-25 | Reiterated | Oppenheimer | Outperform |
| Apr-21-25 | Reiterated | Piper Sandler | Overweight |
| Apr-21-25 | Reiterated | Pivotal Research Group | Buy |
| Apr-21-25 | Reiterated | Wells Fargo | Overweight |
| Apr-17-25 | Resumed | Piper Sandler | Overweight |
| Mar-27-25 | Initiated | FBN Securities | Outperform |
| Mar-17-25 | Upgrade | MoffettNathanson | Neutral → Buy |
| Jan-24-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-23-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-22-25 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-22-25 | Reiterated | Oppenheimer | Outperform |
| Jan-22-25 | Reiterated | Pivotal Research Group | Buy |
| Jan-22-25 | Upgrade | Rosenblatt | Neutral → Buy |
| Jan-22-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Jan-16-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Jan-15-25 | Reiterated | BMO Capital Markets | Outperform |
| Jan-15-25 | Reiterated | Oppenheimer | Outperform |
| Jan-08-25 | Reiterated | Goldman | Neutral |
| Jan-06-25 | Reiterated | Argus | Buy |
| Jan-03-25 | Reiterated | The Benchmark Company | Sell |
| Dec-19-24 | Reiterated | UBS | Buy |
| Dec-16-24 | Downgrade | Loop Capital | Buy → Hold |
| Dec-16-24 | Reiterated | Oppenheimer | Outperform |
| Dec-11-24 | Reiterated | JP Morgan | Overweight |
| Nov-20-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-18-24 | Reiterated | Needham | Buy |
| Oct-18-24 | Reiterated | Oppenheimer | Outperform |
| Oct-18-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-16-24 | Reiterated | Loop Capital | Buy |
| Oct-11-24 | Reiterated | Guggenheim | Buy |
| Oct-10-24 | Reiterated | Morgan Stanley | Overweight |
| Oct-10-24 | Reiterated | Oppenheimer | Outperform |
| Oct-07-24 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-01-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Sep-05-24 | Initiated | China Renaissance | Hold |
| Aug-30-24 | Reiterated | Pivotal Research Group | Buy |
| Jul-17-24 | Reiterated | Guggenheim | Buy |
| Jul-16-24 | Reiterated | The Benchmark Company | Sell |
| Jul-15-24 | Reiterated | BofA Securities | Buy |
| Jul-12-24 | Reiterated | JP Morgan | Overweight |
| Jul-10-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-09-24 | Reiterated | TD Cowen | Buy |
| Jul-02-24 | Reiterated | Argus | Buy |
| May-28-24 | Reiterated | Evercore ISI | Outperform |
| Apr-19-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-19-24 | Upgrade | Needham | Hold → Buy |
| Apr-19-24 | Reiterated | Pivotal Research Group | Buy |
| Apr-15-24 | Reiterated | Deutsche Bank | Hold |
| Apr-12-24 | Reiterated | Morgan Stanley | Overweight |
| Apr-12-24 | Reiterated | Piper Sandler | Neutral |
| Apr-05-24 | Reiterated | Pivotal Research Group | Buy |
| Mar-25-24 | Reiterated | Citigroup | Neutral |
| Mar-12-24 | Reiterated | Jefferies | Buy |
| Mar-11-24 | Reiterated | Oppenheimer | Outperform |
| Jan-30-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jan-25-24 | Upgrade | DZ Bank | Hold → Buy |
| Jan-24-24 | Reiterated | BMO Capital Markets | Outperform |
| Jan-24-24 | Reiterated | BofA Securities | Buy |
| Jan-24-24 | Reiterated | Canaccord Genuity | Buy |
| Jan-24-24 | Reiterated | Evercore ISI | Outperform |
| Jan-24-24 | Reiterated | Goldman | Neutral |
| Jan-24-24 | Reiterated | Guggenheim | Buy |
| Jan-24-24 | Reiterated | JP Morgan | Overweight |
| Jan-24-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-24-24 | Upgrade | Macquarie | Neutral → Outperform |
| Jan-24-24 | Reiterated | Morgan Stanley | Overweight |
| Jan-24-24 | Reiterated | Oppenheimer | Outperform |
| Jan-24-24 | Reiterated | Piper Sandler | Neutral |
| Jan-24-24 | Reiterated | Pivotal Research Group | Buy |
| Jan-24-24 | Reiterated | Redburn Atlantic | Buy |
| Jan-24-24 | Reiterated | Robert W. Baird | Outperform |
| Jan-24-24 | Reiterated | TD Cowen | Outperform |
| Jan-24-24 | Reiterated | UBS | Buy |
| Jan-24-24 | Reiterated | Wells Fargo | Overweight |
| Sep-18-23 | Reiterated | Evercore ISI | Outperform |
| Aug-25-23 | Upgrade | Loop Capital | Hold → Buy |
| Jul-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-17-23 | Reiterated | Deutsche Bank | Buy |
| Jul-13-23 | Reiterated | JP Morgan | Overweight |
| Jul-12-23 | Reiterated | UBS | Buy |
| Jul-05-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-29-23 | Reiterated | Citigroup | Buy |
| Jun-28-23 | Reiterated | Oppenheimer | Outperform |
| Jun-13-23 | Reiterated | BofA Securities | Buy |
| Jun-13-23 | Reiterated | Guggenheim | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Jefferies | Buy |
| Apr-19-23 | Reiterated | Piper Sandler | Neutral |
| Apr-19-23 | Reiterated | Pivotal Research Group | Buy |
| Apr-19-23 | Reiterated | Rosenblatt | Neutral |
| Apr-19-23 | Upgrade | UBS | Neutral → Buy |
| Apr-11-23 | Resumed | Robert W. Baird | Neutral |
| Jan-23-23 | Reiterated | Argus | Buy |
| Jan-20-23 | Reiterated | Canaccord Genuity | Buy |
| Jan-20-23 | Reiterated | Deutsche Bank | Buy |
| Jan-20-23 | Reiterated | Evercore ISI | Outperform |
| Jan-20-23 | Reiterated | Goldman | Sell |
| Jan-20-23 | Reiterated | Guggenheim | Buy |
| Jan-20-23 | Reiterated | Jefferies | Buy |
| Jan-20-23 | Reiterated | MoffettNathanson | Market Perform |
| Jan-20-23 | Reiterated | Oppenheimer | Outperform |
| Jan-20-23 | Reiterated | Piper Sandler | Neutral |
| Jan-20-23 | Reiterated | Pivotal Research Group | Buy |
| Jan-20-23 | Reiterated | Robert W. Baird | Neutral |
| Jan-20-23 | Reiterated | The Benchmark Company | Sell |
| Jan-20-23 | Reiterated | Wedbush | Outperform |
| Jan-20-23 | Reiterated | Wolfe Research | Outperform |
| Jan-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-04-23 | Initiated | New Street | Neutral |
| Dec-29-22 | Upgrade | CFRA | Sell → Buy |
| Dec-14-22 | Reiterated | Jefferies | Hold |
| Dec-09-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-14-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Jun-10-22 | Downgrade | Goldman | Neutral → Sell |
| May-16-22 | Upgrade | Wedbush | Neutral → Outperform |
| Apr-21-22 | Downgrade | DZ Bank | Buy → Hold |
| Apr-21-22 | Downgrade | Edward Jones | Buy → Hold |
| Apr-20-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-20-22 | Downgrade | BofA Securities | Buy → Underperform |
| Apr-20-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-20-22 | Upgrade | Needham | Underperform → Hold |
| Apr-20-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-20-22 | Downgrade | Pivotal Research Group | Buy → Sell |
| Apr-20-22 | Downgrade | Stifel | Buy → Hold |
| Apr-20-22 | Downgrade | UBS | Buy → Neutral |
| Apr-20-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-19-22 | Initiated | Rosenblatt | Neutral |
| Mar-09-22 | Upgrade | Wedbush | Underperform → Neutral |
| Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-31-22 | Upgrade | Edward Jones | Hold → Buy |
| Jan-24-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-21-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-21-22 | Reiterated | BofA Securities | Buy |
| Jan-21-22 | Reiterated | Canaccord Genuity | Buy |
| Jan-21-22 | Reiterated | Cowen | Outperform |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Goldman | Neutral |
| Jan-21-22 | Reiterated | Guggenheim | Buy |
| Jan-21-22 | Reiterated | JP Morgan | Overweight |
| Jan-21-22 | Reiterated | MoffettNathanson | Neutral |
| Jan-21-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Jan-21-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-21-22 | Reiterated | Oppenheimer | Outperform |
| Jan-21-22 | Reiterated | Piper Sandler | Overweight |
| Jan-21-22 | Reiterated | Pivotal Research Group | Buy |
| Jan-21-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Upgrade | The Benchmark Company | Sell → Hold |
| Jan-21-22 | Downgrade | Truist | Buy → Hold |
| Jan-21-22 | Reiterated | UBS | Buy |
| Jan-21-22 | Reiterated | Wolfe Research | Outperform |
| Dec-15-21 | Reiterated | The Benchmark Company | Sell |
| Oct-20-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Sep-29-21 | Reiterated | The Benchmark Company | Sell |
| Sep-13-21 | Initiated | Goldman | Neutral |
| Sep-08-21 | Reiterated | JP Morgan | Overweight |
| Sep-07-21 | Reiterated | Atlantic Equities | Overweight |
| Jul-21-21 | Reiterated | Credit Suisse | Outperform |
| Jul-21-21 | Reiterated | Deutsche Bank | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jun-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-25-21 | Initiated | Edward Jones | Hold |
| May-19-21 | Resumed | Jefferies | Buy |
| Apr-21-21 | Resumed | Oppenheimer | Outperform |
| Apr-21-21 | Reiterated | Pivotal Research Group | Buy |
| Apr-21-21 | Upgrade | Stifel | Hold → Buy |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Apr-01-21 | Initiated | Piper Sandler | Overweight |
| Mar-25-21 | Reiterated | The Benchmark Company | Sell |
| Mar-23-21 | Upgrade | Argus | Hold → Buy |
| Jan-21-21 | Upgrade | DZ Bank | Hold → Buy |
| Jan-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Jan-20-21 | Reiterated | Pivotal Research Group | Buy |
| Jan-20-21 | Reiterated | The Benchmark Company | Sell |
| Jan-20-21 | Upgrade | UBS | Neutral → Buy |
| Jan-20-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-21-20 | Reiterated | BMO Capital Markets | Outperform |
| Oct-21-20 | Reiterated | Bernstein | Outperform |
| Oct-21-20 | Reiterated | Jefferies | Buy |
| Oct-21-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-21-20 | Reiterated | Oppenheimer | Outperform |
| Oct-21-20 | Reiterated | Piper Sandler | Overweight |
| Oct-21-20 | Reiterated | Pivotal Research Group | Buy |
| Oct-21-20 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-21-20 | Reiterated | The Benchmark Company | Sell |
| Oct-21-20 | Reiterated | Wedbush | Underperform |
| Oct-21-20 | Reiterated | Wells Fargo | Equal Weight |
| Oct-16-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-15-20 | Reiterated | Canaccord Genuity | Buy |
| Oct-14-20 | Reiterated | Goldman | Buy |
| Oct-07-20 | Reiterated | Pivotal Research Group | Buy |
| Sep-28-20 | Reiterated | The Benchmark Company | Sell |
| Sep-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-20 | Resumed | Raymond James | Mkt Perform |
| Sep-04-20 | Reiterated | The Benchmark Company | Sell |
| Jul-29-20 | Reiterated | Loop Capital | Buy |
View All
Netflix Inc Stock (NFLX) Latest News
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
After Failed Hostile Takeover Bid, David Ellison's Paramount Skydance Sues Warner Bros. Over Netflix Deal - Yahoo Finance UK
Netflix's Bid to Acquire Warner Bros. Discovery Just Got a Boost From an Unlikely Source - The Globe and Mail
Netflix stock falls after hours as Reuters reports possible all-cash Warner Bros bid shift - TechStock²
Netflix’s first original video podcasts feature Pete Davidson and Michael Irvin - Yahoo
$304M Film Studio is Coming to Bushwick, Twice as Big as Netflix’s Johnson Ave HQ - Bushwick Daily
How Netflix Stock Can Rally Again? - Forbes
Netflix may switch to a cash offer for Warner Bros. - Yahoo! Finance Canada
As Trump Casts Doubt on the Netflix-Warner Bros. Discovery Deal, How Should You Play NFLX Stock? - Barchart.com
Could Netflix Throw More Cash Into Its Warner Bros. Deal? Investors Are Wondering - Investopedia
Netflix Stock Falls Amid Warner Bros Acquisition Battle - GuruFocus
The Attention Wars: Why Netflix Is Buying the Past to Own the Future - Competitive Enterprise Institute
When Cinema Goes Live: Netflix Storytelling Brought to Life by IDZ, Joyca, and TVU Networks - Yahoo Finance
Netflix Reportedly Considering All-Cash WBD Offer 01/14/2026 - MediaPost
Netflix stock falls 2% as all-cash Warner Bros bid talk collides with lawsuit and earnings - TechStock²
Netflix stock slips as all-cash Warner Bros bid talk swirls, with earnings days away - TechStock²
Michael Irvin to Debut Netflix Podcast The White House - Netflix
Netflix Stock Dips Amid All-Cash Bid for Warner Bros. Rumors - Schaeffer's Investment Research
Netflix prepares all-cash offer for Warner Bros, source says - Reuters
NFLX Stock In Focus Amid Reports It Could Change WBD Offer To An All-Cash Bid: Retail Says It's A Signal Of Organic Growth Becoming Expensive - Stocktwits
Netflix Considers All-Cash Bid for Warner Bros, Strong Financing Capability - Intellectia AI
Netflix Ad-Tier Growth Accelerates: Is the Stock Finally Breaking Out? - Zacks Investment Research
The Zacks Analyst Blog Highlights Netflix, Toyota Motor, Amphenol, Oil-Dri and Global Self Storage - Yahoo Finance
Netflix likely to adjust Warner Bros. Discovery offer to make it all-cash - CNBC
Netflix Stock Is Rising. Watch This One Thing as the Warner Bidding War Unfolds. - Barron's
BMO Capital reiterates Outperform rating on Netflix stock amid growth concerns - Investing.com India
Countdown to Netflix (NFLX) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
Netflix Stock Trending as Analysts Eye Upside - TipRanks
Do You Believe in the Long-Term Growth Potential of Netflix (NFLX)? - Yahoo Finance
Netflix wins 'KPop Demon Hunters' domain name after failing to register it - Mashable
Ahead of Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued? - Morningstar
What Could Light a Fire Under Netflix Stock - Trefis
Netflix ‘plans to switch to all-cash offer to seal $83bn Warner Bros deal’ - The Guardian
Netflix reportedly mulls switch to all-cash bid for WB studios and streaming business - Screen Daily
Netflix Set to Make All-Cash Offer for Warner Bros, Sources Say - Meyka
Netflix Inc (NASDAQ:NFLX) Nasdaq 100 Composition Technology Media Model - Kalkine Media
Netflix stock pops on report of all-cash bid for Warner Bros. - MSN
Could This Fuel The Next Surge in Netflix Stock - Trefis
Netflix Q4 2025 results preview: what investors should watch - ig.com
Netflix revises WBD acquisition plan amid stock decline and rival challenge - Adgully.com
Netflix has discussed revising its cash-and-stock deal for the Warner Bros. studios and streaming assets to all cash, according to a Bloomberg report. Read more below. - Facebook
Netflix Stock Under Pressure As Warner Bros. Deal Saga Spills Over - Asianet Newsable
Netflix could amend Warner Bros bid to make it all cash, Bloomberg reports - The Edge Malaysia
Paramount demands information about Netflix agreement in Warner suit - Canadian Lawyer Magazine
Netflix is preparing to make an all-cash offer for Warner Brossource - marketscreener.com
Netflix mulls switch to all-cash bid for WB studios and streaming business (reports) - Screen Daily
Netflix Confirms Production of ‘The Dealer,’ a High-Stakes Casino Crime Series With Producer Hwang Dong-hyuk - About Netflix
Netflix weighs amending Warner Bros bid to make it all cash, Bloomberg reports - The Spokesman-Review
Congressmen Sell Netflix Stock Ahead Of NFL Games, 'Stranger Things' Finale: Will They Miss Profits? - Benzinga
Netflix Prepping All-Cash Bid for Warner Bros. Studios and HBO Max Amid Paramount Skydance Pressure: Report - IMDb
Netflix stock edges up after report it may go all-cash on Warner Bros assets - TechStock²
Netflix Inc Stock (NFLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):